Timeline And Progress

Home/About NANOSOLUTIONS/Timeline And Progress

African countries plan nanosafety network

A number of African nations have decided to establish a network to build capacity on the safety of nanomaterials. The decision was taken at a workshop in Lusaka, Zambia, organised by the UN Institute for Training and Research (Unitar) and Zambia’s Environmental Management Agency (Zema), with funding from Switzerland. Georg

March 16th, 2016|

Small clumps in the body: how nanoparticles react to proteins

Scientists at the INM – Leibniz Institute for New Materials have found out that the protein haemoglobin influences the aggregation of individual gold nanoparticles to form clumps. James Bond can be located anywhere. He owes this fact to the nanosensors that find their way into his bloodstream by way of injection

March 8th, 2016|

The EuroScience Open Forum offers a first look at the 2016 Programme

The EuroScience Open Forum has announced its 2016 programme. With keynote speakers including Professor Dame Sally Davies, the UK's Chief Medical Officer, right through to Commissioner Moedas from the European Commission; and sessions on science and technology and their impact on our societies, space exploration and pushing the frontiers of

February 15th, 2016|

New NANOSOLUTIONS film – Safer by Design

More and more nano materials are being used in products we use every day, but in order to ensure this proliferation can deliver the innovation society needs, we must ensure that they are safe to use. At the moment, this is both time consuming and expensive. NANOSOLUTIONS is an EU-funded

December 1st, 2015|

Learning from nature

The opening keynote lecture at The Systems Biology in Nanosafety Research conference, taking place at the Karolinska Institute, in Stockholm, brought the perspectives of a material scientist to the forum with a fascinating talk by Professor Olli Ikkala. Professor Ikkala, of the Department of Applied Physics and Centre of Excellence

November 11th, 2015|

Spreading the NANOSOLUTIONS word

IPL recently hosted the latest NANOSOLUTIONS dissemination committee meeting, at which committee members discussed the current work of different work packages, the NANOSOLUTIONS safety Classifier and plans by IPL to increase communications activity now that results are beginning to emerge from the project’s experiments. At the core of this communication

October 23rd, 2015|

WP 12 – Safety Classification

Lang Tran The development and application of ENMs promises many benefits to both society and the global economy. However, to ensure responsible development of this emerging technology, governance must be put into place to ensure that any potential risk posed by ENMs are fully understood and controlled. The regulatory landscape

November 16th, 2014|

WP11- Systems biology analysis

Dario Greco One of the main goals of the NANOSOLUTIONS consortium is to create an ENM classifier - a model that can predict the effect of any given nanomaterial. This is being done through what is known as machine learning; we are essentially training a computer programme to know what

November 16th, 2014|

WP8 – Disease Models

Fritz Krombach Inhalation of rigid multi-wall carbon nanotubes induces allergic asthma-like symptoms in mice The overall goal of WP8 is to identify the key physicochemical properties and surface modifications of engineered nanomaterials (ENM) that control their fate and biological and toxic effects in cells and tissues from susceptible individuals. For

November 16th, 2014|

WP7 – Cross species models

Richard Handy A fundamental part of developing a classification system for nanomaterial safety is to identify the toxic effects that different ENMs have across a wide range of organisms, from microbes to mammals, and on different body systems. These effects are assessed by their overall magnitude of toxicity ¬– low

November 16th, 2014|

WP6 – Cell models

Bengt Fadeel and Lucian Farcal WP6 works on the application of in vitro methods for the assessment of nanomaterial (NM) immunotoxicity and genotoxicity. The hypothesis is that refined in vitro assays can replace in vivo testing of NMs. To achieve this goal, WP6 partners selected and refined the SOPs for

November 16th, 2014|

WP5 – ENM bio-nanointeraction in biological media

Marco Monopoli The overall objective of WP5 is to clarify the ‘biological identity’ of ENMs before and after they have entered into cells or organisms so that the relationship between the ENM surface (biomolecule corona composition) and mechanisms of toxicity (identified in WP7-10) can be understood. As soon as nanomaterials

November 16th, 2014|

WP4 – Life-cycle analysis

Socorro Vázquez-Campos WP4 is devoted to studying the transformation and release of engineered nanomaterials (ENMs) along their life cycle (production, manufacturing, use and disposal) when used in existing applications or industrial processes, and the assessment of the environmental and health impacts of these releases. Researchers have so far performed a

November 16th, 2014|

WP3 – Materials

Erik Larsen and Manuel Correia The first half of 2014 consisted of finishing the synthesis of the engineered nanomaterials (ENMs), which has now been completed. Present work, which is ongoing, involves the basic characterisation and development of dispersion protocols for the powder materials. Up until now, more than half of

November 16th, 2014|